These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25752765)

  • 1. Vaginal Lactobacillus gasseri CMUL57 can inhibit herpes simplex type 2 but not Coxsackievirus B4E2.
    Kassaa IA; Hober D; Hamze M; Caloone D; Dewilde A; Chihib NE; Drider D
    Arch Microbiol; 2015 Jun; 197(5):657-64. PubMed ID: 25752765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of herpes simplex virus type 2 by vaginal lactobacilli.
    Conti C; Malacrino C; Mastromarino P
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 6():19-26. PubMed ID: 20224147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal Lactobacilli Supernatants Protect from Herpes Simplex Virus Type 1 Infection in Cell Culture Models.
    Avitabile E; Menotti L; Giordani B; Croatti V; Parolin C; Vitali B
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines.
    Mousavi E; Makvandi M; Teimoori A; Ataei A; Ghafari S; Samarbaf-Zadeh A
    J Chin Med Assoc; 2018 Mar; 81(3):262-267. PubMed ID: 29037754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
    Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The application of a plasmid DNA encoding IFN-alpha 1 postinfection enhances cumulative survival of herpes simplex virus type 2 vaginally infected mice.
    Härle P; Noisakran S; Carr DJ
    J Immunol; 2001 Feb; 166(3):1803-12. PubMed ID: 11160227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Effect of Retro-2.1 against Herpes Simplex Virus Type 2 In Vitro.
    Dai W; Wu Y; Bi J; Wang J; Wang S; Kong W; Barbier J; Cintrat JC; Gao F; Jiang Z; Gillet D; Su W; Jiang C
    J Microbiol Biotechnol; 2018 Jun; 28(6):849-859. PubMed ID: 29847864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-HSV-2 effect of alumen: In vitro and in vivo experimental studies.
    Hong L; Xu X; Chen L; Li B; Wu D; Hu M; Sun Q; Zhu X; Wu W; Hong S; Ding W; Min J; Xu Q
    J Huazhong Univ Sci Technolog Med Sci; 2011 Dec; 31(6):828-833. PubMed ID: 22173507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization.
    Gallichan WS; Rosenthal KL
    J Infect Dis; 1998 May; 177(5):1155-61. PubMed ID: 9592997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A VP26-mNeonGreen Capsid Fusion HSV-2 Mutant Reactivates from Viral Latency in the Guinea Pig Genital Model with Normal Kinetics.
    Pieknik JR; Bertke AS; Tang S; Krause PR
    Viruses; 2018 May; 10(5):. PubMed ID: 29738431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectivity and growth kinetics of Herpes Simplex Virus type-2 in MOLT4 CCR5+ and CEM CCR5+ T cell lines.
    Desai D; Bhutkar M; Kulkarni S
    Microb Pathog; 2018 Oct; 123():82-88. PubMed ID: 29944889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes Simplex Virus Growth, Preparation, and Assay.
    Sutter SO; Marconi P; Meier AF
    Methods Mol Biol; 2020; 2060():57-72. PubMed ID: 31617172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenoxazine derivatives suppress the infections caused by herpes simplex virus type-1 and herpes simplex virus type-2 intravaginally inoculated into mice.
    Hayashi K; Hayashi T; Miyazawa K; Tomoda A
    J Pharmacol Sci; 2010; 114(1):85-91. PubMed ID: 20736512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antiviral activity of Lactobacillus acidophilus and Glycyrrhiza glabra against Herpes Simplex-1 Virus (HSV-1) and Vesicular Stomatitis Virus (VSV): experimental and In Silico insights.
    Elebeedy D; Ghanem A; Aly SH; Ali MA; Faraag AHI; El-Ashrey MK; Salem AM; Hassab MAE; Maksoud AIAE
    BMC Microbiol; 2023 Jun; 23(1):173. PubMed ID: 37391715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections.
    Whaley KJ; Zeitlin L; Barratt RA; Hoen TE; Cone RA
    J Infect Dis; 1994 Mar; 169(3):647-9. PubMed ID: 8158042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A short-term plaque assay for antiviral drug research on herpes simplex virus type 2.
    Muratore O; Tonoli EL; Pesce Schito A
    New Microbiol; 1996 Jul; 19(3):257-61. PubMed ID: 8841042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral and virucidal activities against herpes simplex viruses of umesu phenolics extracted from Japanese apricot.
    Nishide M; Ikeda K; Mimura H; Yoshida M; Mitani T; Hajime Koyama A
    Microbiol Immunol; 2019 Sep; 63(9):359-366. PubMed ID: 31301156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
    Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
    Front Immunol; 2018; 9():2932. PubMed ID: 30619292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.